We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Surgical Glue Helps Repair Heart Defects

By HospiMedica International staff writers
Posted on 23 Jan 2014
A flexible, elastic, hydrophobic light-activated adhesive (HLAA) could help seal defects in the heart wall.

Developed by researchers at Brigham and Women's Hospital (Boston, MA, USA), HLAA is a blood-resistant surgical glue for the minimally invasive repair of vessels and heart defects, with unique chemical and physical properties that include high viscosity, hydrophobicity, and on-demand curing. More...
Based on a mixture of easily metabolized glycerol and sebacic acid, the adhesive can be brushed on a biological surface and set in seconds with a short application of ultraviolet (UV) light. In a porcine model the HLAA adhesive succeeded in providing a strong hemostatic seal of high-pressure large blood vessels and cardiac wall defects.

The HLAA-coated patches were attached to the interventricular septum in a beating porcine heart and were able to resist supraphysiologic pressures by remaining attached for 24 hours. Unlike glues that work through a chemical reaction, HLAA works by mechanical means, becoming physically entangled with collagen and other proteins on the tissue surface. The researchers suggest that the adhesive could be used for the repair of vascular defects and achieving surgical hemostasis in human intracardiac interventions and other surgical applications. The study was published in the January 8, 2014, issue of Science Translational Medicine.

“Sutures and staples have major drawbacks. Staples, which work by piercing tissue, can cause damage, and putting in sutures is time consuming,” said lead author Jeffrey Karp, PhD, of the division of biomedical engineering. “Replacing these tools with rubbery, fast-acting adhesives could help make surgeries faster and less invasive, and potentially prevent complications.”

The HLAA cardiac adhesive is being developed as a commercial product by Gecko Biomedical (Paris, France).

Related Links:
Gecko Biomedical


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.